A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants
Clinical trial NCT07311226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07311226
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2026-06-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.